Roku, Merck, and Schwab Stocks Reach New Heights Amid Earnings Momentum

Roku's stock soared to a 52-week high of $158.51 on Monday after the company reported stronger-than-expected Q2 2026 results, with revenue reaching $1.35 billion and a significant increase in active households.

The acquisition by Fox Corporation for $22 billion also contributed to the surge in investor sentiment, as Roku's platform and advertising growth continue to outperform expectations.

Merck & Co Inc shares also reached a 52-week high of $137.17 on Monday, driven by strong Q2 earnings beat and positive clinical trial momentum for its oncology portfolio, including Keytruda sales rising 4% to $8.4 billion.

Charles Schwab Corp stock jumped to an annual high but closed down 0.44% after reporting a record month of core net new assets, with total client assets equalling $13.04 trillion and daily average trades reaching 11.6 million.